Visualization of telomerase reverse transcriptase (hTERT) promoter activity using a trimodality fusion reporter construct

Journal of Nuclear Medicine

Volumn 47, Issue 2, 2006, Pages 270-277

  Padmanabhan, Parasuraman ^a   Otero, Jesse ^b   Ray, Pritha ^a   Paulmurugan, Ramasamy ^a   Hoffman, Andrew R ^b   Gambhir, Sanjiv S ^a   Biswal, Sandip ^a,d   Ulaner, Gary A ^b,c  

^a STANFORD UNIVERSITY   (United States)

^b VA PALO ALTO HEALTH CARE SYSTEM   (United States)

^c UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^d STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Molecular imaging; Reporter genes; Telomerase; Telomerase reverse transcriptase

Indexed keywords

8 PENCICLOVIR H 3; ACICLOVIR DERIVATIVE; FLUOROURACIL; MONOMERIC RED FLUORESCENCE PROTEIN 1; RADIOISOTOPE; RED FLUORESCENT PROTEIN; RENILLA LUCIFERIN 2 MONOOXYGENASE; TELOMERASE REVERSE TRANSCRIPTASE; THYMIDINE KINASE; UNCLASSIFIED DRUG; ANTINEOPLASTIC AGENT; HYBRID PROTEIN; TELOMERASE; TUMOR PROTEIN;

ARTICLE; BIOLUMINESCENCE; CONTROLLED STUDY; DRUG EFFECT; ENZYME ACTIVITY; FLUORESCENCE MICROSCOPY; GENE CONSTRUCT; GENE EXPRESSION; GENE FUSION; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; NON INVASIVE PROCEDURE; PRIORITY JOURNAL; REPORTER GENE; TUMOR CELL LINE; TUMOR GENE; TUMOR GROWTH; CELL SURVIVAL; ENZYME ACTIVATION; GENE EXPRESSION PROFILING; GENETICS; METABOLISM; METHODOLOGY; NEOPLASM; PROMOTER REGION; SCINTISCANNING;

ANTINEOPLASTIC AGENTS; CELL LINE, TUMOR; CELL SURVIVAL; ENZYME ACTIVATION; FLUOROURACIL; GENE EXPRESSION PROFILING; GENES, REPORTER; HUMANS; NEOPLASM PROTEINS; NEOPLASMS; PROMOTER REGIONS (GENETICS); RECOMBINANT FUSION PROTEINS; TELOMERASE;

EID: 34248678300     PISSN: 01615505     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (18)

1. Granger MP, Wright WE, Shay JW. Telomerase in cancer and aging. Crit Rev Oncol Hematol. 2002;41:29-40.
2. Maser RS, DePinho RA. Connecting chromosomes, crisis, and cancer. Science. 2002;297:565-569.
3. Feng J, Funk WD, Wang SS, et al. The RNA component of human telomerase. Science. 1995;269:1236-1241.
4. Nakamura TM, Morin GB, Chapman KB, et al. Telomerase catalytic subunit homologs from fission yeast and human. Science. 1997;277:955-959.
5. Ducrest AL, Szutorisz H, Lingner J, Nabholz M. Regulation of the human telomerase reverse transcriptase gene. Oncogene. 2002;21:541-552.
6. Hiyama E, Hiyama K. Telomerase as tumor marker. Cancer Lett. 2003;194:221-233.
7. Lee KH, Rudolph KL, Ju YJ, et al. Telomere dysfunction alters the chemotherapeutic profile of transformed cells. Proc Natl Acad Sci U S A. 2001;98:3381-3386.
8. Sawant SG, Gregoire V, Dhar S, et al. Telomerase activity as a measure for monitoring radiocurability of tumor cells. FASEB J. 1999;13:1047-1054.
9. Groot-Wassink T, Aboagye EO, Wang Y, Lemoine NR, Keith WN, Vassaux G. Noninvasive imaging of the transcriptional activities of human telomerase promoter fragments in mice. Cancer Res. 2004;64:4906-4911.
10. Massoud TF, Gambhir SS. Molecular imaging in living subjects: seeing fundamental biological processes in a new light. Genes Dev. 2003;17:545-580.
11. Ulaner GA, Hu JF, Vu TH, Giudice LC, Hoffman AR. Telomerase activity in human development is regulated by human telomerase reverse transcriptase (hTERT) transcription and by alternate splicing of hTERT transcripts. Cancer Res. 1998;58:4168-4172.
12. Ray P, De A, Min JJ, Tsien RY, Gambhir SS. Imaging tri-fusion multimodality reporter gene expression in living subjects. Cancer Res. 2004;64:1323-1330.
13. Gambhir SS, Bauer E, Black ME, et al. A mutant herpes simplex virus type 1 thymidine kinase reporter gene shows improved sensitivity for imaging reporter gene expression with positron emission tomography. Proc Natl Acad Sci U S A. 2000;97:2785-2790.
14. Henson JD, Neumann AA, Yeager TR, Reddel RR. Alternative lengthening of telomeres in mammalian cells. Oncogene. 2002;21:598-610.
15. Bryan TM, Englezou A, Dalla-Pozza L, Dunham MA, Reddel RR. Evidence for an alternative mechanism for maintaining telomere length in human tumors and tumor-derived cell lines. Nat Med. 1997;3:1271-1274.
16. Majumdar AS, Hughes DE, Lichtsteiner SP, Wang Z, Lebkowski JS, Vasserot AP. The telomerase reverse transcriptase promoter drives efficacious tumor suicide gene therapy while preventing hepatotoxicity encountered with constitutive promoters. Gene Ther. 2001;8:568-578.
17. Wick M, Zubov D, Hagen G. Genomic organization and promoter characterization of the gene encoding the human telomerase reverse transcriptase (hTERT). Gene. 1999;232:97-106.
18. Horikawa I, Cable PL, Mazur SJ, Appella E, Afshari CA, Barrett JC. Downstream E-box-mediated regulation of the human telomerase reverse transcriptase (hTERT) gene transcription: evidence for an endogenous mechanism of transcriptional repression. Mol Biol Cell. 2002;13:2585-2597.